Data collected from this web page will not be passed on to third parties. It will not be used for any other purpose than to contact you regarding your request. All data will be deleted upon your request or as soon as they are no longer needed in order to contact you regarding your request.
Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.